An­tiox­i­dants can beat colon can­cer

The Sun (Malaysia) - - WHAT2EAT -

A STUDY, pub­lished re­cently by the Jour­nal of Can­cer, has re­vealed the ther­a­peu­tic ef­fects of two an­tiox­i­dant com­pounds when com­bined to fight colon can­cer.

Cur­cumin is the ac­tive in­gre­di­ent in turmeric ( above), al­ready known for its an­ti­in­flam­ma­tory prop­er­ties, whereas sily­marin, a com­po­nent of milk this­tle, has been used to treat liver dis­ease.

In lab­o­ra­tory tests, re­searchers from Saint Louis Univer­sity in the US found that colon can­cer cells stopped mul­ti­ply­ing and spread­ing, and that cell death in­creased when ex­posed to the two nat­u­ral com­pounds.

When ex­pos­ing colon can­cer cell cul­tures to cur­cumin – the polyphe­nol that gives curry dishes their bright yel­low colour – and then to sily­marin, found in the milk this­tle plant, re­searchers saw ben­e­fi­cial ef­fects from this pair of nat­u­ral ex­tracts.

The sci­en­tists found that the com­bi­na­tion of these two nat­u­ral com­pounds stopped the mul­ti­pli­ca­tion of can­cer cells and in­creased cell death.

Sev­eral pre­vi­ous stud­ies have high­lighted the ben­e­fi­cial prop­er­ties of cur­cumin, such as its anti-in­flam­ma­tory na­ture, its abil­ity to lower triglyc­eride lev­els or its ca­pac­ity to boost cog­ni­tive health by com­bat­ting Alzheimer’s and Parkin­son’s dis­ease.

The com­pound’s anti-can­cer prop­er­ties have pre­vi­ously been ob­served in breast can­cer and prostate can­cer re­search.

Sily­marin is a com­po­nent of milk this­tle – a plant of the Aster­aceae fam­ily – which is ben­e­fi­cial to the liver.

In 1989, the Euro­pean Com­mis­sion ap­proved the use of a stan­dard­ised con­cen­tra­tion of 70-80% of sily­marin in the treat­ment of toxic liver dam­age and for sup­port­ive treat­ment in chronic in­flam­ma­tory liver dis­ease and he­patic cir­rho­sis.

In 2002, the World Health Or­gan­i­sa­tion recog­nised sim­i­lar uses.

The sci­en­tists’ dis­cov­ery re­veals a promis­ing al­ter­na­tive ap­proach to stan­dard colon can­cer treat­ments, avoid­ing prob­lems with tox­i­c­ity and side ef­fects. Still, fur­ther test­ing is re­quired. – AFP-Re­laxnews

Newspapers in English

Newspapers from Malaysia

© PressReader. All rights reserved.